Mostrar el registro sencillo del ítem
| dc.contributor.author | Rodríguez-Lozano, Francisco-Javier | |
| dc.contributor.author | Pérez-Guzmán, Nuria | |
| dc.contributor.author | García-Ríos, Paula | |
| dc.contributor.author | García-Bernal, David | |
| dc.contributor.author | Mora, Alejandro | |
| dc.contributor.author | López-García, Sergio | |
| dc.date.accessioned | 2026-03-10T11:55:50Z | |
| dc.date.available | 2026-03-10T11:55:50Z | |
| dc.date.issued | 2026-02 | |
| dc.identifier.citation | Rodríguez-Lozano FJ, Pérez-Guzmán N, García-Rios P, García-Bernal D, Mora A, López-García S. In Vitro Evaluation of Novel Resin-Modified Calcium Silicate Cements for Minimally Invasive Vital Pulp Therapy. International Dental Journal. febrero de 2026;76(1):109299. doi:10.1016/j.identj.2025.109299 | |
| dc.identifier.issn | 0020-6539 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/25363 | |
| dc.description.abstract | OBJECTIVES: This study aimed to evaluate the biological effects of one conventional calcium silicate-based cement (MTA Angelus) and three resin-modified formulations (TheraCal PT, TheraBase Ca, and TheraCal LC) on human dental pulp stem cells (hDPSCs), focusing on cytocompatibility, cellular behaviour, and odontogenic/mineralization potential. METHODS: hDPSCs were cultured with material extracts at different dilutions (1:1, 1:2, 1:4). Cytocompatibility was assessed using MTT assay, wound-healing migration, and immunofluorescence for cytoskeletal organization. Cell adhesion and morphology were examined by SEM, while material composition was analysed by EDX. Odontogenic/osteogenic differentiation was evaluated through qRT-PCR for ALP, RUNX2, COL1A1, DSPP, BSP, and ON at 3 and 7 days, and extracellular matrix mineralization was quantified by Alizarin Red S staining at 21 days. Results were compared with untreated controls (P < .05). RESULTS: MTA Angelus exhibited the most favourable biological performance (P < .001), with high cytocompatibility, strong upregulation of odontogenic genes, and abundant mineralized nodule formation. TheraCal PT showed intermediate outcomes, with higher gene expression and mineralization capacity than TheraBase Ca (P < .001). TheraBase Ca provided the best cytocompatibility and cell adhesion among resin-modified cements (P < .05) but induced moderate differentiation and mineralization. In contrast, TheraCal LC displayed the lowest cell viability, impaired migration, and limited mineralization potential (P < .001). CONCLUSION: MTA Angelus remains the benchmark material for vital pulp therapy due to its robust bioactivity, while TheraCal PT and TheraBase Ca emerge as promising resin-modified alternatives, each with distinct biological advantages. TheraCal LC, however, demonstrated limited cytocompatibility and regenerative potential. CLINICAL SIGNIFICANCE: These findings highlight the importance of material selection in vital pulp therapy. Resin-modified calcium silicate cements may serve as alternatives, but MTA Angelus continues to offer the most predictable biological outcomes for pulp preservation and repair. | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Calcium Compounds/pharmacology/chemistry | |
| dc.subject.mesh | Silicates/pharmacology/chemistry | |
| dc.subject.mesh | Dental Pulp/cytology/drug effects | |
| dc.subject.mesh | Stem Cells/drug effects | |
| dc.subject.mesh | In Vitro Techniques | |
| dc.subject.mesh | Dental Cements/pharmacology | |
| dc.subject.mesh | Materials Testing | |
| dc.subject.mesh | Cell Differentiation/drug effects | |
| dc.subject.mesh | Drug Combinations | |
| dc.subject.mesh | Aluminum Compounds/pharmacology | |
| dc.subject.mesh | Cells, Cultured | |
| dc.subject.mesh | Cell Adhesion/drug effects | |
| dc.subject.mesh | Resin Cements/pharmacology | |
| dc.subject.mesh | Cell Movement/drug effects | |
| dc.subject.mesh | Odontogenesis/drug effects | |
| dc.subject.mesh | Osteogenesis/drug effects | |
| dc.subject.mesh | Bismuth | |
| dc.subject.mesh | Oxides | |
| dc.title | In Vitro Evaluation of Novel Resin-Modified Calcium Silicate Cements for Minimally Invasive Vital Pulp | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 41308279 | |
| dc.relation.publisherversion | https://linkinghub.elsevier.com/retrieve/pii/S002065392508582X | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1016/j.identj.2025.109299 | |
| dc.journal.title | International Dental Journal | |
| dc.identifier.essn | 1875-595X |